Protocol Library
Each card lists peptide research notes — vial size, example research dose range, reconstitution example, frequency example, cycle length example, and risk level. All entries are educational. Not medical advice.
CJC-1295 (no DAC)
low riskResearched in growth hormone pulse research, often paired with GHRPs.
- Vial
- 2 mg
- Dose
- 100 mcg per use (research literature)
- Freq
- 1–3x daily (research example)
- Cycle
- 8–12 weeks (research example)
CJC-1295 with DAC
moderate riskResearched in studies of sustained GH/IGF-1 elevation.
- Vial
- 2 mg
- Dose
- 1–2 mg weekly (research literature)
- Freq
- 1–2x weekly (research example)
- Cycle
- 8–12 weeks (research example)
FOXO4-DRI
high riskInvestigated for disruption of FOXO4–p53 interaction in senescent cells.
- Vial
- 5 mg lyophilized vial
- Dose
- Educational research dose example only; preclinical literature.
- Freq
- Pulsed protocols in research designs.
- Cycle
- Short pulsed cycles.
GHK-Cu
low riskResearched in dermal repair, hair follicle, and anti-aging contexts.
- Vial
- 50 mg
- Dose
- 1–2 mg per use (research literature)
- Freq
- Topical or subq (research example)
- Cycle
- 4–8 weeks (research example)
GLOW Blend (BPC-157 + TB-500 + GHK-Cu)
moderate riskStudied as a combined research peptide profile for repair-related endpoints.
- Vial
- Blend vial (varies by source)
- Dose
- Educational research dose example only.
- Freq
- Daily or alternating-day research designs.
- Cycle
- 4–8 week educational example.
Glutathione
low riskResearched as a master antioxidant in oxidative stress contexts.
- Vial
- 600 mg
- Dose
- 200–600 mg per use (research literature)
- Freq
- 1–3x weekly (research example)
- Cycle
- 4–8 weeks (research example)
Ipamorelin
low riskResearched as a selective ghrelin receptor agonist in GH studies.
- Vial
- 5 mg
- Dose
- 100–300 mcg per use (research literature)
- Freq
- 1–3x daily (research example)
- Cycle
- 8–12 weeks (research example)
Melanotan II
high riskResearched in melanocortin pathway studies.
- Vial
- 10 mg
- Dose
- 250–500 mcg per use (research literature)
- Freq
- Variable (research example)
- Cycle
- 4 weeks (research example)
SNAP-8
low riskInvestigated for SNARE complex modulation in topical cosmetic research.
- Vial
- Topical research solution
- Dose
- Educational research concentration example only.
- Freq
- Topical research application example.
- Cycle
- Multi-week educational example.
Vilon
low riskInvestigated for immunomodulatory and chromatin-related signaling research.
- Vial
- 20 mg lyophilized vial
- Dose
- Educational research dose example only.
- Freq
- Daily in short research cycles.
- Cycle
- 10–20 day educational example.
Looking for a research supplier?
Enhanced Performance is a separate research supply platform. Visiting or purchasing is optional and not required to use PepToolbox.
Disclosure: Enhanced Performance is a separate platform connected to the owner of this website. Purchasing is optional and not required to use this tool.